Risk Appetite EXPLODES on 90% Effective COVID-19 Vaccine
Matt Weller, CFA, CMT November 9, 2020 1:21 PM
In the words of Pfizer CEO Albert Bourla, “We can see the light at the end of the [COVID-19 pandemic] tunnel”
In results that the CEO of Pfizer hailed as a “great day for science and humanity,” the company announced that its COVID-19 vaccine was found to be more than 90% effective in Phase 3 trials. This efficacy exceeds most scientists wildest dreams; previously NIH Director Anthony Fauci had said that a 50-60% effective vaccine would be “acceptable” and most scientists were hoping for something in the 70% range. The study included over 43,000 participants.
Moving forward, Pfizer and vaccine co-creator BioNTech have indicated that they plan to apply for emergency use authorization from the US FDA in two weeks’ time. Assuming no setbacks, the firms expect to produce 50 million doses of the vaccine in 2020 and 1.3 billion doses in 2021, raising hopes of a potential “return to normal” in the middle of next year for much of the developed world.
Combined with the resolution of the US election this weekend, traders have multiple reasons for optimism as the week kicks off. That said, the market moves aren’t necessarily a one-way street. While futures on the more “old world” S&P 500 and Dow Jones Industrial Average indices are surging 4-5% ahead of the open, the technology-heavy Nasdaq is actually poised to open marginally lower on the day. Many of the massive technology behemoths (think Apple, Amazon, Facebook, Netflix, Alphabet/Google, and Microsoft) as well as smaller stay-at-home centric rivals (Zoom Video, Fastly, Peloton, Shopify, Nvidia, etc) will now face a much tougher competitive landscape sooner than expected. To wit, futures on the small-cap focused Russell 2000 index are trading “limit up” (+7%), meaning that the index can’t advance further until markets officially open.
Source: TradingView, GAIN Capital
Outside of equities, the reaction is a bit more intuitive. In the FX market, growth-sensitive currencies like the “commodity dollars” (AUD, NZD, and CAD) are surging along with emerging market currencies, while traditional safe havens like the JPY, CHF, and USD are lagging. Likewise, gold is trading down by nearly 4% while WTI cruide oil is up by nearly 10%(!). Finally, the yield on the benchmark 10-year US Treasury bond is trading up 11bps to 0.92%, signaling optimism and risk appetite across the globe.
Source: TradingView, GAIN Capital
While the hard-working scientists at Pfizer and BioNTech are still putting the finishing touches on their research, traders are buying first and asking questions later. In the words of Pfizer CEO Albert Bourla, “We can see the light at the end of the [COVID-19 pandemic] tunnel”, and not a moment too soon with global infection rates setting new records, hospitals nearing capacity, and economies struggling to reopen.
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.